Jason Zemmel > McDermott Will & Emery UK LLP > London, England > Lawyer Profile
McDermott Will & Emery UK LLP Offices
22 Bishopsgate
London
EC2N 4BQ
England
- Firm Profile
- Go to...
Jason Zemmel
Work Department
Corporate Advisory
Position
Jason Zemmel focuses his practice on private equity and mergers and acquisitions matters with a particular focus on health and social care transactions. Jason has pan European experience advising a wide range of clients, including private equity sponsors, management teams, corporates, and advisers on corporate matters, including leveraged buyouts, mergers and acquisitions, disposals and management incentive programmes, together with related advisory work.
Read full biography here: https://www.mwe.com/people/zemmel-jason/
Lawyer Rankings
London > Corporate and commercial > Private equity: transactions - mid-market deals (up to £500m)
(Leading partners)Especially noted for its capabilities in the healthcare and life sciences sectors, McDermott Will & Emery UK LLP frequently advises on high-value, cross-border transactions. The team has been bolstered by a number of recent arrivals. Jason Zemmel is an experienced healthcare specialist who arrived from CMS in October 2024. Fatema Orjela, who joined the firm from Sidley Austin in April 2024, is highly regarded for her transactional experience in a host of sectors and jurisdictions, while Sebastien Bonneau – who joined from Eversheds Sutherland in September 2024 – handles a wide array of international transactions, particularly in the data centre and digital infrastructure sector. Other key figures include Eleanor West, who is especially experienced in healthcare and pharmaceutical work.
Lawyer Rankings
- Leading partners London > Corporate and commercial > Private equity: transactions - mid-market deals (up to £500m)
- Private equity: transactions - mid-market deals (up to £500m) London > Corporate and commercial
Top Tier Firm Rankings
Firm Rankings
- Dispute resolution > Commercial litigation: mid-market
- Finance > Debt capital markets
- Industry focus > Emerging markets
- Industry focus > Life sciences and healthcare
- Corporate and commercial > M&A: Lower Mid-Market Deals, £100m-£750m
- Private client > Personal tax, trusts and probate
- Finance > Acquisition finance
- Finance > Derivatives and structured products
- Risk advisory > ESG
- Finance > High yield
- Dispute resolution > International arbitration
- Corporate and commercial > Private equity: transactions - mid-market deals (up to £500m)
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Finance > Bank lending: investment grade debt and syndicated loans
- Finance > Corporate restructuring & insolvency
- Corporate and commercial > Corporate tax
- Real estate > Property finance
- Projects, energy and natural resources > Renewables
- Employment > Employers